Increased plasma levels of the soluble form of Fas ligand in patients with acute myocardial infarction and unstable angina pectoris

Journal of the American College of Cardiology

Volumn 39, Issue 4, 2002, Pages 585-590

  Shimizu, Masumi ^a   Fukuo, Keisuke ^a   Nagata, Shigekazu ^a   Suhara, Toshimitsu ^a   Okuro, Masashi ^a   Fujii, Kenshi ^b   Higashino, Yorihiko ^b   Mogi, Masaki ^a   Hatanaka, Yasuko ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Sakurabashi Watanabe Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; CORONARY ANGIOGRAPHY; FAS LIGAND PROTEIN; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYOCARDIAL INFARCTION; SEVERITY OF ILLNESS INDEX; SOLUBILITY; TIME FACTORS;

EID: 0037138501     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01800-9     Document Type: Article

References (33)

1. Apoptosis in the pathogenesis and treatment of disease
2. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of humans with myocardial infarction
3. Apoptosis in human acute myocardial infarction
4. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes
5. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53
6. Stretch-induced programmed myocyte cell death
7. Tumor necrosis factor-alpha-induced apoptosis in cardiac myocytes: Involvement of the sphingolipid signaling cascade in cardiac cell death
8. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2
9. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor
10. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation
11. Apoptosis by death factor
12. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils
13. Fas ligand-induced apoptosis as a mechanism of immune privilege
14. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
15. The cardiac Fas (APO-1/CD95) receptor/Fas ligand system: Relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes
16. Proinflammatory consequences of transgenic Fas ligand expression in the heart
17. Fas ligand in human serum
18. Levels of soluble Fas ligand in myocarditis
19. Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure
20. Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head iniury
21. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS)
22. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure
23. Unstable angina: A classification
24. Macrophage infiltration in acute coronary syndromes: Implications for plaque rupture
25. Downregulation of Fas ligand by shedding
26. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes
27. Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes
28. Hydrogen peroxide induces up-regulation of Fas in human endothelial cells
29. Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO-1/Fas) ligand expression in microglial cells
30. Caspase-1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand
31. Regulation of the proinflammatory effects of Fas ligand (CD95L)
32. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes
33. Chemotactic activity of soluble Fas ligand against phagocytes